Note: Should you have landed here as a result of a search engine (or other) link, be advised that these files contain material that is copyrighted by the American Medical Association. You are forbidden to download the files unless you read, agree to, and abide by the provisions of the copyright statement. Read the copyright statement now and you will be linked back to here.

Contractor's Policy Number

98-1A-R1

Contractor's Name

CareFirst of Maryland Inc., Medicare Part A

Contractor Number

00190

Contractor Type

Fiscal Intermediary

LMRP Title

Radiation Carrier

AMA CPT Copyright Statement

CPT codes, descriptions, and other data only are copyright 1999 American Medical Association (or such publication of CPT). All rights reserved. Applicable FARS/DFARS clauses apply.

CMS National Coverage Policy

Primary Geographic Jurisdiction

Maryland

Washington, DC

Secondary Geographic Jurisdiction

Alabama, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Iowa, Kansas, Kentucky, Louisiana, Maine, Massachusetts, Michigan, Missouri, Nebraska, Nevada, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Pennsylvania, South Carolina, South Dakota, Tennessee, Texas, Utah, Virginia, Wisconsin, Washington state, and Wyoming

CMS Region

Region III

CMS Consortium

Northeast

Original Policy Effective Date

02/12/1998

Original Policy Ending Date

NA

Revision Effective Date

NA

Revision Ending Date

NA

LMRP Description

Radiation carriers are safe and effective devices used to administer radiation to confined areas by means of capsules, beads, or needles of emitting radiation materials such as radium or cesium.

Indications and Limitations of Coverage and/or Medical Necessity

The function of the device is to hold the radiation source securely in the same location during the entire period of treatment. Radiation oncologists generally use these devices to achieve close approximation and controlled application of radiation to a tumor that is susceptible to radiation. Only a radiation oncologist may report the preparation and supply of radiation carriers. The radiation carriers should be included in the procedure charge. Medicare would not expect to see the radiation carriers billed separately.

CPT/HCPCS Section & Benefit Category

Surgery/Musculoskeletal System

Type of Bill Code

Not separately billable

Revenue Codes

Not separately billable

CPT/HCPCS Codes

21089 Unlisted maxillofacial prosthetic procedure

Not Otherwise Classified (NOC)

NA

ICD-9 Codes that Support Medical Necessity

Covered for:

140.0   Upper lip, vermilion border
140.1   Lower lip, vermilion border
140.3   Upper lip, inner aspect
140.4   Lower lip, inner aspect
140.5   Lip, unspecified, inner aspect
140.6   Commissure of lip
140.8   Other sites of lip
140.9   Lip, unspecified, vermilion border
141.0   Base of tongue
141.1   Dorsal surface of tongue
141.2   Tip and lateral border of tongue
141.3   Ventral surface of tongue
141.4   Anterior two-thirds of tongue, part unspecified
141.5   Junctional zone
141.6   Lingual tonsil
141.8   Other sites of tongue
141.9   Tongue unspecified
142.0   Parotid gland
142.1   Submandibular gland
142.2   Sublingual gland
142.8   Other major salivary glands
142.9   Salivary gland, unspecified
143.0   Upper gum
143.1   Lower gum
143.8   Other sites of gum
143.9   Gum, unspecified
144.0   Anterior portion
144.1   Lateral portion
144.8   Other sites of floor of mouth
144.9   Floor of mouth, part unspecified
145.0   Check mucosa
145.1   Vestibule of mouth
145.2   Hard palate
145.3   Soft palate
145.4   Uvula
145.5   Palate, unspecified
145.6   Retromolar area
145.8   Other specified parts of mouth
145.9   Mouth, unspecified
146.0   Tonsil
146.1   Tonsillar fossa
146.2   Tonsillar pillars (anterior) (posterior)
146.3   Vallecula
146.4   Anterior aspect of epiglottis
146.5   Junctional region
146.6   Lateral wall of oropharynx
146.7   Posterior wall of oropharynx
146.8   Other specified sites of oropharynx
146.9   Oropharynx, unspecified
147.0   Superior wall
147.1   Posterior wall
147.2   Lateral wall
147.3   Anterior wall
147.8   Other specified sites of nasopharynx
147.9   Nasopharynx, unspecified
148.0   Postcricoid region
148.1   Pyriform sinus
148.2   Aryepiglottic fold, hypopharyngeal aspect
148.3   Posterior hypopharyngeal wall
148.8   Other specified sites of hypopharynx
148.9   Hypopharynx , unspecified
149.0   Pharynx, unspecified
149.1   Waldeyer's ring
149.8   Other
149.9   Ill-defined
161.0   Glottis
161.1   Supraglottis
161.2   Subglottis
161.3   Laryngeal cartilages
161.8   Other specified sites of larynx
161.9   Larynx, unspecified
170.0   Bones of skull and face, except mandible
170.1   Mandible
171.0   Head, face, and neck
176.8   Other specified sites
195.0   Head, face, and neck
196.0   Lymph nodes of head, face, and neck
196.8   Lymph nodes of multiple sites
200.00   Reticulosarcoma, unspecified site, extranodal and solid organ sites
200.01   Reticulosarcoma, lymph nodes of head, face, and neck
200.08   Reticulosarcoma, lymph nodes of multiple sites
200.10   Lymphosarcoma, unspecified site, extranodal and solid organ sites
200.11   Lymphosarcoma, lymph nodes of head, face, and neck
200.18   Lymphosarcoma, lymph nodes of multiple sites
200.20   Burkitt's tumor or lymphoma, unspecified site, extranodal and solid organ sites
200.21   Burkitt's tumor or lymphoma, lymph nodes of head, face, and neck
200.28   Burkitt's tumor or lymphoma, lymph nodes of multiple sites
200.80   Other named variants, unspecified site, extranodal and solid organ sites
200.81   Other named variants, lymph nodes of head, face, and neck
200.88   Other named variants, lymph nodes of multiple sites
201.00   Hodgkin's paragranuloma, unspecified site, extranodal and solid organ sites
201.01   Hodgkin's paragranuloma, lymph nodes of head, face, and neck
201.08   Hodgkin's paragranuloma, lymph nodes of multiple sites
201.10   Hodgkin's granuloma, unspecified site, extranodal and solid organ sites
201.11   Hodgkin's granuloma, lymph nodes of head, face, and neck
201.18   Hodgkin's granuloma, lymph nodes of multiple sites
201.20   Hodgkin's sarcoma, unspecified site, extranodal and solid organ sites
201.21   Hodgkin's sarcoma, lymph nodes of head, face, and neck
201.28   Hodgkin's sarcoma, lymph nodes of multiple sites
201.40   Lymphocytic-histiocytic predominance, unspecified site, extranodal and solid organ sites
201.41   Lymphocytic-histiocytic predominance, lymph nodes of head, face, and neck
201.48   Lymphocytic-histiocytic predominance, lymph nodes of multiple sites
201.50   Nodular sclerosis,unspecified site, extranodal and solid organ sites
201.51   Nodular sclerosis, lymph nodes of head, face, and neck
201.58   Nodular sclerosis, lymph nodes of multiple sites
201.60   Mixed cellularity, unspecified site, extranodal and solid organ sites
201.61   Mixed cellularity, lymph nodes of head, face, and neck
201.68   Mixed cellularity, lymph nodes of multiple sites
201.70   Lymphocytic depletion, unspecified site, extranodal and solid organ sites
201.71   Lymphocytic depletion, lymph nodes of head, face, and neck
201.78   Lymphocytic depletion, lymph nodes of multiple sites
201.90   Hodgkin's disease unspecified, unspecified site, extranodal and solid organ sites
201.91   Hodgkin's disease unspecified,lymph nodes of head, face, and neck
201.98   Hodgkin's disease unspecified,lymph nodes of multiple sites
202.00   Hodgkin's disease unspecified, unspecified site, extranodal and solid organ sites
202.01   Hodgkin's disease unspecified,lymph nodes of head, face, and neck
202.08   Hodgkin's disease unspecified,lymph nodes of multiple sites
202.20   Sezary's disease, unspecified site, extranodal and solid organ sites
202.21   Sezary's disease,lymph nodes of head, face, and neck
202.28   Sezary's disease,lymph nodes of multiple sites
202.30   Malignant histiocytosis, unspecified site, extranodal and solid organ sites
202.31   Malignant histiocytosis, lymph nodes of head, face, and neck
202.38   Malignant histiocytosis, lymph nodes of multiple sites
202.40   Leukemic reticuloendotheliosis, unspecified site, extranodal and solid organ sites
202.41   Leukemic reticuloendotheliosis, lymph nodes of head, face, and neck
202.48   Leukemic reticuloendotheliosis, lymph nodes of multiple sites
202.50   Letterer-Siwe disease, unspecified site, extranodal and solid organ sites
202.51   Letterer-Siwe disease, lymph nodes of head, face, and neck
202.58   Letterer-Siwe disease, lymph nodes of multiple sites
202.60   Malignant mast cell tumors, unspecified site, extranodal and solid organ sites
202.61   Malignant mast cell tumors, lymph nodes of head, face, and neck
202.68   Malignant mast cell tumors, lymph nodes of multiple sites
202.80   Other lymphomas, unspecified site, extranodal and solid organ sites
202.81   Other lymphomas, lymph nodes of head, face, and neck
202.88   Other lymphomas, lymph nodes of multiple sites
202.90   Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue
    unspecified site, extranodal and solid organ sites
202.91   Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue, lymph nodes of head,
    face, and neck
202.98   Other and unspecified malignant neoplasms of lymphoid and histiocytic tissue,lymph nodes of multiple
    sites
235.0   Major salivary glands
235.1   Lip, oral cavity, and pharynx
235.9   Other and unspecified respiratory organs

Diagnoses that Support Medical Necessity

As listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy

ICD-9 Codes that DO NOT Support Medical Necessity

Any diagnosis codes not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy

Diagnoses that DO NOT Support Medical Necessity

Conditions not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy.

Reasons for Denial

Non-covered ICD-9 Codes

Any diagnosis codes not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy

Non-covered Diagnoses

Conditions not listed in the "ICD-9 Codes that Support Medical Necessity" section of this policy.

Coding Guidelines

Documentation Requirements

Utilization Guidelines

Medicare will monitor the utilization of this laboratory test through the Medical Review process.

Other Comments

NA

Sources of Information and Basis for Decision

Advisory Committee Notes

This policy does not reflect the sole opinion of the contractor or Contractor Medical Director. Although the final decision rests with the contractor, this policy was developed in cooperation with advisory groups , which includes representatives from the appropriate specialty(ies).

Advisory Committee Meeting Date: NA

Start Date of Comment Period

11/12/1997

End Date of Comment Period

NA

Start Date of Notice Period

01/12/1998

Revision History

Number Date Change
98-1A-R1   08/20/2002   Converted to required format, mandatory fields completed, ICD-9 codes unranged.
         
         
         

 

THIS BULLETIN SHOULD BE SHARED WITH ALL HEALTH CARE PRACTITIONERS AND MANAGERIAL MEMBERS OF THE PROVIDER/SUPPLIER STAFF. BULLETINS ISSUED AFTER OCTOBER 1, 1999 ARE AVAILABLE FROM OUR WEBSITE AT www.marylandmedicare.com

Italicized and or quoted material is excerpted from the American Medical Association Current Procedural Terminology CPT codes, descriptions and other data only are copyrighted 1999 American Medical Association (or such other publication of CPT). All rights reserved. Applicable FARS/DFARS apply.